Significant Ownership of SUVRETTA CAPITAL MANAGEMENT, LLC

Signature - Title
By: /s/ Andrew Nathanson - Andrew Nathanson,General Counsel and Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by SUVRETTA CAPITAL MANAGEMENT, LLC.

Notify me when SUVRETTA CAPITAL MANAGEMENT, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of SUVRETTA CAPITAL MANAGEMENT, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BNTC Benitec Biopharma Inc. Common Stock, par value $0.0001 44% $249,200,088 +$30,000,153 17,761,945 +14% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Nov 2025
Veradermics, Inc Common Stock, par value $0.00001 12% 4,168,991 SUVRETTA CAPITAL MANAGEMENT, LLC 05 Feb 2026
IFRX InflaRx N.V. Common Shares, nominal value (euro)0.12 per share 12% $8,647,962 7,933,910 SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025
MOLN MOLECULAR PARTNERS AG Common Shares, CHF 0.10 nominal value per share 11% $17,696,249 4,284,806 SUVRETTA CAPITAL MANAGEMENT, LLC 15 Jun 2021
WHWK Aadi Bioscience, Inc. Common Stock, par value $0.0001 per share 10% $7,280,365 4,727,510 SUVRETTA CAPITAL MANAGEMENT, LLC 04 Mar 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 9.9% $129,451,408 15,176,015 SUVRETTA CAPITAL MANAGEMENT, LLC 07 Apr 2025
AVBP ArriVent BioPharma, Inc. Common Stock, $0.0001 Par Value per Share 9.9% $75,183,720 3,412,788 Suvretta Capital Management, LLC 30 Jun 2025
KURA Kura Oncology, Inc. Common Stock, par value $0.0001 per share 9.4% $49,222,110 +$15,381,900 7,561,000 +45% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Mar 2025
FULC Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share 9.4% $18,495,988 +$6,069,154 5,067,394 +49% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Mar 2025
ZURA Zura Bio Limited Class A Ordinary Shares, $0.0001 par value 8.6% $29,171,085 5,567,001 SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025
IMTX Immatics N.V. ordinary shares, nominal value (euro)0.01 per share 8.3% $117,496,354 -$8,820,000 11,190,129 -7% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025
CMPX Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share 8.2% $44,559,662 +$21,967,265 14,101,159 +97% Suvretta Capital Management, LLC 13 Aug 2025
BHVN Biohaven Ltd. Common Shares, no par value 7.8% $116,139,519 10,286,937 SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025
AURA Aura Biosciences, Inc. Common Stock, par value $0.00001 per share 7.6% $30,091,360 +$10,524,518 4,701,775 +54% Suvretta Capital Management, LLC 30 Jun 2025
PVLA Palvella Therapeutics, Inc. Common stock, $0.001 par value per share 7.4% $51,556,256 +$6,766,571 822,400 +15% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Sep 2025
CAPR Capricor Therapeutics, Inc. Common Stock, par value $0.001 per share 6.6% $80,730,585 3,417,891 SUVRETTA CAPITAL MANAGEMENT, LLC 19 Feb 2026
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 5.6% $121,716,000 -$93,071,712 8,280,000 -43% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Sep 2025
GLUE Monte Rosa Therapeutics, Inc. Common stock, par value $0.0001 per share 5.5% $17,539,200 3,360,000 SUVRETTA CAPITAL MANAGEMENT, LLC 09 Apr 2025
MRNS Marinus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.5% $1,662,437 +$504,541 3,022,612 +44% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Feb 2025
ABEO Abeona Therapeutics Inc. Common Stock, $0.01 par value 5.2% $15,627,840 2,676,000 Suvretta Capital Management, LLC 30 Jun 2025
ERAS Erasca, Inc. Common Stock, $0.0001 par value per share 5.1% $20,592,846 +$3,105,540 14,502,004 +18% Suvretta Capital Management, LLC 30 Jun 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 0.9% $354,000 -$1,605,900 300,000 -82% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Jun 2025
STRO Sutro Biopharma, Inc. Common Stock, $0.001 par value 0% $0 -$75,099,106 0 -100% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025

Schedules 13D/G Reported by SUVRETTA CAPITAL MANAGEMENT, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.